What is the appropriate management for a 5‑year‑old child presenting with influenza‑like illness and calf pain?

Management of a 5-Year-Old with Flu-Like Symptoms and Calf Pain

This child most likely has benign acute childhood myositis (BACM) complicating influenza infection and requires immediate creatine kinase (CK) monitoring, aggressive hydration, and consideration of oseltamivir if presenting within 48 hours of symptom onset.

Immediate Assessment and Diagnosis

The combination of flu-like symptoms with calf pain in a 5-year-old is highly suggestive of BACM, a self-limited complication that typically occurs during or shortly after influenza infection, most commonly influenza B 1, 2, 3. This child requires:

• Immediate CK measurement - BACM characteristically shows markedly elevated CK levels (average 4,000-5,000 U/L, though can exceed 13,000 U/L) 1, 3
• Influenza testing - Nasopharyngeal aspirate or nose/throat swabs for rapid diagnosis 4
• Assessment of ambulation - Children with BACM typically have severe bilateral calf pain with difficulty or refusal to walk 1, 5

Antiviral Treatment Decision

Oseltamivir should be initiated if the child has been symptomatic for ≤48 hours, regardless of test results, given the high clinical suspicion for influenza. 4

For a 5-year-old child:

• Dosing: Weight-based oseltamivir dosing 4:
  • 15-23 kg (typical for age 3-7 years): 45 mg every 12 hours
  • ≥24 kg: 75 mg every 12 hours
• Duration: Continue for 5 days
• Timing: Do not delay treatment while awaiting test results, as early therapy provides optimal outcomes 4

The British Infection Society/British Thoracic Society guidelines specifically recommend oseltamivir as the antiviral agent of choice for children, noting it reduces complications including secondary bacterial infections 4.

Antibiotic Consideration

Co-amoxiclav should be added if there are signs of secondary bacterial infection or severe illness. 4

Indications for antibiotics in this scenario:

• Evidence of pneumonia (respiratory distress, hypoxia, abnormal chest examination) 4
• High fever persisting beyond typical viral course
• Clinical deterioration

For children under 12 years, co-amoxiclav is the drug of choice, providing coverage against S. pneumoniae, Staph. aureus, and H. influenzae - the most common secondary bacterial pathogens in influenza 4.

Management of BACM

The cornerstone of BACM management is aggressive hydration and daily CK monitoring until downtrending. 1, 3

Hydration Protocol

• Oral hydration if tolerated 3, 5
• IV fluids if oral intake inadequate or CK extremely elevated (>10,000 U/L) 1
• Goal: Prevent progression to rhabdomyolysis and acute kidney injury

Monitoring Requirements

• Daily CK levels until consistent downtrend observed 1
• Monitor renal function (creatinine, BUN) if CK >5,000 U/L 1
• Assess urine output and color (myoglobinuria risk)

Symptomatic Management

• Non-steroidal anti-inflammatory drugs for pain control 3
• Rest and activity restriction until symptoms resolve
• Typical resolution: 3-7 days 1, 2, 5

Critical Red Flags Requiring Hospitalization

Admit if any of the following are present 4:

• Oxygen saturation ≤92% on room air
• Inability to maintain oral intake
• CK >10,000 U/L with rising trend
• Signs of acute kidney injury (decreased urine output, elevated creatinine)
• Severe respiratory distress
• Altered mental status

Common Pitfalls to Avoid

Do not dismiss calf pain as simple myalgia - BACM can progress to severe rhabdomyolysis if not properly managed with hydration 1, 5. The most severe reported case had CK >13,000 U/L 1.

Do not withhold oseltamivir based on negative rapid antigen tests - These tests have poor sensitivity (10-80%) and should not guide treatment decisions in high-risk or symptomatic children 4.

Do not use corticosteroids - There is a conditional recommendation against corticosteroids in severe influenza 6.

Do not assume BACM only follows influenza B - While most common with influenza B 2, 3, BACM has been documented with influenza A and parainfluenza viruses 7.

Outpatient vs. Inpatient Decision

Outpatient management is appropriate if:

• CK <5,000 U/L with adequate oral hydration 3
• No respiratory distress or hypoxia
• Reliable follow-up for daily CK monitoring available
• Child can ambulate with assistance

Hospitalization required if:

• Any red flags listed above present
• Inadequate oral intake or vomiting (oseltamivir side effect occurs in 15% of children) 4
• Unreliable follow-up for CK monitoring